Cost-effectiveness and public health impact of RTS,S/AS01E malaria vaccine in Malawi, using a Markov static model [version 2; peer review: 2 approved]

Background: The RTS,S/AS01E malaria vaccine is being assessed in Malawi, Ghana and Kenya as part of a large-scale pilot implementation programme. Even if impactful, its incorporation into immunisation programmes will depend on demonstrating cost-effectiveness. We analysed the cost-effectiveness and...

Full description

Bibliographic Details
Main Authors: Latif Ndeketa, Donnie Mategula, Dianne J. Terlouw, Naor Bar-Zeev, Christophe J. Sauboin, Sophie Biernaux
Format: Article
Language:English
Published: Wellcome 2021-08-01
Series:Wellcome Open Research
Online Access:https://wellcomeopenresearch.org/articles/5-260/v2